NASDAQ · Key Statistics

Celularity Inc. (CELU) Key Statistics

$0.98 NASDAQ: CELU Market Cap $31.73M

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Celularity Inc. (CELU), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-0.58
P/B ratioShare price divided by book value per share.	-0.85
P/S ratioMarket value divided by annual revenue.	1.80
PEG ratioP/E divided by the earnings growth rate.	-0.01
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	-1.84
EV / RevenueEnterprise value against annual revenue.	3.70
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-217.39%
Free cash flow yieldFree cash flow as a percentage of market value.	-26.57%

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	94.80%
Operating marginRevenue left after operating costs.	-264.27%
Net marginRevenue left after every cost, including tax and interest.	-246.73%
Return on equityProfit as a percentage of shareholders’ equity.	142.86%
Return on assetsProfit as a percentage of total assets.	-47.89%
Return on capital employedOperating profit against the capital the business uses.	-135.41%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	0.11
Quick ratioThe same, excluding inventory.	0.10
Cash ratioCash alone against current liabilities.	0.07
Debt to equityTotal borrowings against shareholders’ equity.	-1.01
Debt to assetsTotal borrowings against total assets.	0.38
Interest coverageHow many times operating profit covers the interest bill.	-22.43

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-3.59
Book value per shareShareholders’ equity divided by shares outstanding.	$0.00
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$31.73M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$68.42M
EmployeesReported headcount.	120

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%
Payout ratioShare of profit paid out as dividends.	0.00%

Celularity Inc. (CELU) statistics — frequently asked questions

What is Celularity Inc.'s P/E ratio?

Celularity Inc. (CELU) trades on a price-to-earnings ratio of -0.58. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Celularity Inc.'s return on equity?

Celularity Inc. (CELU) reports a return on equity of 142.86%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Celularity Inc. carry?

Celularity Inc. (CELU) has a debt-to-equity ratio of -1.01, which compares total borrowings with shareholders' equity.

What is Celularity Inc.'s profit margin?

Celularity Inc. (CELU) keeps -246.73% of revenue as net profit after every cost, including tax and interest.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.